3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
13
Motor Activity
12
Fatigue
6
Lymphedema
4
Depression
4
Neoplasms
3
Neoplasm Metastasis
3
Multiple Myeloma
3
Head and Neck Neoplasms
3
Breast Cancer Lymphedema
3
Anxiety Disorders
3
Respiratory Aspiration
2
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Lung Neoplasms
2
Hypoventilation
2
Ventricular Dysfunction, Left
1
Uterine Cervical Neoplasms
1
Trismus
1
Triple Negative Breast Neoplasms
1
Stomach Neoplasms
1
Solid Tumor Cancer
1
Sarcoma
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Postoperative Complications
1
Peripheral Nervous System Diseases
1
Pain
1
Osteosclerosis
1
Osteoarthritis, Knee
1
Interventions
Radiotherapy
4
Paclitaxel
4
Carboplatin
4
Sodium Chloride
3
Oxaliplatin
3
Cyclophosphamide
3
Vincristine
2
Surveys and Questionnaires
2
Procarbazine
2
Prednisolone
2
Methotrexate
2
Mental Status and Dementia Tests
2
Magnetic Resonance Spectroscopy
2
Magnesium Sulfate
2
Leucovorin
2
Duloxetine Hydrochloride
2
Doxorubicin
2
Dexamethasone
2
Cytarabine
2
Calcium Gluconate
2
Amifostine
2
Acupuncture Therapy
2
neurotropin
1
motexafin gadolinium
1
haloperidol decanoate
1
glutamic acid diethyl ester
1
glucarpidase
1
fludarabine phosphate
1
fludarabine
1
axicabtagene ciloleucel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Neurotoxicity Syndromes
×
Exercise Therapy
×
Clear all
NCT04583124
2025-11-18
ATENTO
Universidad de Granada
Phase NA
Completed
42 enrolled